Publications - Jacqueline A . Leavitt, M.D.

Back to Research Profile

1. Elmalem VI, Younge BR, Biousse V, Leavitt JA, Moster ML, Warner J, Kupersmith MJ, Landau K, Brodsky MC, Frohman LP, May EF, Tomsak RL, Newman NJ. Clinical course and prognosis of trochlear nerve schwannomas. Ophthalmology 2009 Oct; 116(10):2011-6.
   View PubMed
2. Zaldivar RA, Leavitt JA, Griepentrog GJ, Woog JJ, Bradley EA. Rhino-orbital-cerebral mucormycosis: a lethal complication of body dysmorphic disorder. Ophthal Plast Reconstr Surg 2009 Sep-Oct; 25(5):398-9.
   View PubMed
3. Cornelius JR, Boes CJ, Ghearing G, Leavitt JA, Kumar N. Visual symptoms in the Heidenhain variant of Creutzfeldt-Jakob disease. J Neuroimaging 2009 Jul; 19(3):283-7.
   View PubMed
4. Daniels TB, Pollock BE, Miller RC, Lucchinetti CF, Leavitt JA, Brown PD. Radiation-induced optic neuritis after pituitary adenoma radiosurgery in a patient with multiple sclerosis: case report. J Neurooncol 2009 Jun; 93(2):263-7.
   View PubMed
5. Daniels TB, Pollock BE, Miller RC, Lucchinetti CF, Leavitt JA, Brown PD. Radiation-induced optic neuritis after pituitary adenoma radiosurgery in a patient with multiple sclerosis: case report. J Neurooncol 2009 Jun; 93(2):263-7. Epub 2008 Dec 20.
   View PubMed
6. Adams WE, Leavitt JA, Holmes JM. Strabismus surgery for internuclear ophthalmoplegia with exotropia in multiple sclerosis. J AAPOS 2009 Feb; 13(1):13-5. Epub 2008 Dec 12.
   View PubMed
7. Leavitt JA, Kotagal S. The "cherry red" spot. Pediatr Neurol 2007 Jul; 37(1):74-5.
   View PubMed
8. Hu WT, Leavitt JA, Moore EJ, Noseworthy JH. MRI findings of rapidly progressive ophthalmoplegia and blindness in mucormycosis. Neurology 2006 May 23; 66(10):E40.
   View PubMed
9. Leavitt JA. Diagnosis and management of functional visual deficits. Curr Treat Options Neurol 2006 Jan; 8(1):45-51.
   View PubMed
10. Feldon SE, Levin L, Scherer RW, Arnold A, Chung SM, Johnson LN, Kosmorsky G, Newman SA, Katz J, Langenberg P, Wilson PD, Kelman SE, Dickersin K, Kennerdell J, Bruchis A, Govreau D, Holds J, Selhorst J, Malton M, Rogers A, Saunders T, King K, Fecko T, Development and validation of a computerized expert system for evaluation of automated visual fields from the Ischemic Optic Neuropathy Decompression Trial. BMC Ophthalmology 2006; 6.
    View PubMed
11. Lankaranian D, Altangerel U, Spaeth GL, Leavitt JA, Steinmann WC, Mills RP, Jones DB, Ing MR, Cibis GW, Flach AJ, Eagle RC Jr, Ferris FL. The usefulness of a new method of testing for a relative afferent pupillary defect in patients with ocular hypertension and glaucoma. Trans Am Ophthalmol Soc 2005; 103:200-8.
    View PubMed
12. Lal G, Leavitt JA, Lindor NM, Mahr MA. Unilateral Lisch nodules in the absence of other features of neurofibromatosis 1. Am J Ophthalmol 2003 Apr; 135(4):567-8.
    View PubMed
13. Cook BE Jr, Leavitt JA, Dolan JW, Nichols DA. Carotid cavernous fistula associated with persistent primitive trigeminal artery. J Neuroophthalmol 2000 Dec; 20(4):264-5.
    View PubMed
14. Ing E, Leavitt J, Younge B. Incidence of Pupillary Involvement in Ischemic Oculomotor Nerve Palsies Ann Ophthalmol 2000; 32(2):90-94.
    View PubMed
15. Kelman S, Leavitt J, Ischemic Optic Neuropathy Decompression Trial Research Group. The ischemic optic neuropathy decompression trial (IONDT): design and methods. Controlled Clinical Trials 1998; 19:276-96.
    View PubMed
16. Leavitt JA, Campbell RJ. Cost-effectiveness in the diagnosis of sarcoidosis: the conjunctival biopsy. Eye (Lond) 1998; 12 ( Pt 6):959-62.
    View PubMed
17. Ing EB, Woolf IZ, Younge BR, Bjornsson J, Leavitt JA. Systemic amyloidosis with temporal artery involvement mimicking temporal arteritis. Ophthalmic Surgery & Lasers 1997 Apr; 28(4):328-31.
    View PubMed
18. Sitenga GL, Ing EB, Van Dellen RG, Younge BR, Leavitt JA. Asthma caused by topical application of ketorolac. Ophthalmology 1996 Jun; 103(6):890-2.
    View PubMed
19. Ing EB, Leavitt JA, Younge BR. Papilledema following bowtie optic atrophy. Arch Ophthalmol 1996 Mar; 114(3):356-7.
    View PubMed
20. Kelman S, Leavitt J, Ischemic Optic Neuropathy Decompression Trial Research Group. Characteristics of patients with nonarteritic anterior ischemic optic neuropathy eligible for the Ischemic Optic Neuropathy Decompression Trial. Arch Ophthalmol 1996; 114:1366-74.
    View PubMed
21. Ing EB, Younge BR, Leavitt JA, Fitzpatrick PJ. Functional visual loss and the duochrome rest. Can J Ophthalmol 1995 Feb; 30:35-36.
    View PubMed
22. Ing EB, Younge BR, Leavitt JA, Lee RA, Bostwick DG. Paraneoplastic retinopathy and gynecologic malignancy. Journal of Pelvic Surgery 1995; 1:79-83.
23. Ischemic Optic Neuropathy Decompression Trial Research Group. Optic nerve decompression surgery for nonarteritic anterior ischemic optic neuropathy (NAION) is not effective and may be harmful. The Ischemic Optic Neuropathy Decompression Trial Research Group. JAMA 1995; 273(8):625-632.
    View PubMed
24. Kodsi SR, Younge BR, Leavitt JA, Campbell RJ, Scheithauer BW. Intracranial plasma cell granuloma presenting as an optic neuropathy. Surv Ophthalmol 1993 Jul-Aug; 38(1):70-4.
    View PubMed
25. Beck R, Leavitt J, Optic Neuritis Study Group. The clinical profile of optic neuritis: experience of the optic neuritis treatment trial. Arch Ophthalmol 1991; 109:1673-8.
    View PubMed
26. Cornelius JR, Boes CJ, Ghearing GR, Leavitt JA, Kumar N. Visual symptoms in the Heidenhain variant of Creutzfeldt-Jakob disease Neuroimaging 0 Epub 2008 Sep.
    View PubMed